Author/Creator: Kuhns, Scott - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Kuhns, Scott

1. Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab. Issue 4 (19th May 2018)

Authors:: Seo, Neungseon; Polozova, Alla; Zhang, Mingxuan; Yates, Zachary; Cao, Shawn; Li, Huimin; Kuhns, Scott; Maher, Gwendolyn; McBride, Helen J.; Liu, Jennifer
Journal:: MAbs
Issue:: Volume 10:Issue 4(2018)
Page Start:: 678
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product. (November 2020)

Authors:: Seo, Neungseon; Huang, Zhe; Kuhns, Scott; Sweet, Heather; Cao, Shawn; Wikström, Mats; Liu, Jennifer
Journal:: Biologicals
Issue:: Volume 68(2020)
Page Start:: 79
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody‐dependent cellular cytotoxicity. Issue 11 (19th October 2021)

Authors:: Branstetter, Elaine; Duff, Robert J.; Kuhns, Scott; Padaki, Rupa
Journal:: FEBS open bio
Issue:: Volume 11:Issue 11(2021)
Page Start:: 2943
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Glycan engineering reveals interrelated effects of terminal galactose and core fucose on antibody‐dependent cell‐mediated cytotoxicity. (4th August 2020)

Authors:: Zhang, Qingchun; Joubert, Marisa K.; Polozova, Alla; De Guzman, Ronandro; Lakamsani, Kamala; Kinderman, Francis; Xiang, Dong; Shami, Andrew; Miscalichi, Nahira; Flynn, Gregory C.; Kuhns, Scott
Journal:: Biotechnology progress
Issue:: Volume 36:Number 6(2020)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Non-clinical similarity of biosimilar ABP 798 with rituximab reference product. (July 2021)

Authors:: McBride, Helen J.; Jassem, Shea; Chow, Vincent; Kanakaraj, Palanisamy; Lebrec, Herve; Kuhns, Scott; Ferbas, John; Wong, Min; Thway, Theingi M.
Journal:: Biologicals
Issue:: Volume 72(2021)
Page Start:: 42
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry. Issue 1 (31st December 2022)

Authors:: Woodall, Daniel W.; Dillon, Thomas M.; Kalenian, Kevin; Padaki, Rupa; Kuhns, Scott; Semin, David J.; Bondarenko, Pavel V.
Journal:: MAbs
Issue:: Volume 14:Issue 1(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. S3200 ABP 710, a Biosimilar to Infliximab Reference Product: Supporting Extrapolation of Indications With a Focus on Crohn's Disease. (October 2020)

Authors:: Reinisch, Walter; Halder, Smita; Khan, Waliul I.; Wang, Xuanyu; Kuhns, Scott
Journal:: American journal of gastroenterology
Issue:: Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1
Page Start:: S1678
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Strategies to evaluate potential effector function of glycan variants: a case study of ordesekimab (AMG 714 or PRV-015). Issue 1 (31st December 2022)

Authors:: Wei, Yu-Ling; Wegesser, Teresa; Kuhns, Scott; Werner, Jonathan; Lebrec, Hervé; Wang, Xiaoting
Journal:: Journal of immunotoxicology
Issue:: Volume 19:Issue 1(2022)
Page Start:: 109
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗